AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Patrys Ltd

0.035

0.000

Volume:523.07K

Turnover:18.31K

Market Cap:18.72M

PE:-2.00

High:0.035

Open:0.035

Low:0.035

Close:0.035

52wk High:0.049

52wk Low:0.015

Shares:534.90M

Float Shares:183.00M

Volume Ratio:0.52

T/O Rate:0.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.017

ROE:-143.39%

ROA:-57.40%

PB:25.55

PE(LYR):-2.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Patrys Ltd

Exchange:

ASX

Establishment Date:

2006

Employees:

10

Office Location:

168 Stirling Highway,Nedlands,Western Australia,Australia

Website:

http://www.patrys.com

Zip Code:

6009

Phone:

Fax:

- -

Introduction:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PAB.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","market":"AU","secType":"STK","nameCN":"Patrys Ltd","latestPrice":0.035,"timestamp":1770959520000,"preClose":0.035,"halted":0,"volume":523071,"delay":0,"changeRate":0,"nameEN":"Patrys Ltd","floatShares":183000000,"shares":534900614,"eps":-0.0175,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:12:00 AEDT","open":0.035,"high":0.035,"low":0.035,"amount":18307,"amplitude":0,"askPrice":0.036,"askSize":228249,"bidPrice":0.035,"bidSize":205500,"shortable":3,"etf":0,"ttmEps":-0.0175,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.035,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0.5192595312304034,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","floatShares":183000000,"roa":"-57.40%","roe":"-143.39%","lyrEps":-0.017496,"volumeRatio":0.5192595312304034,"shares":534900614,"dividePrice":0,"high":0.035,"amplitude":0,"preClose":0.035,"low":0.035,"week52Low":0.015,"pbRate":"25.55","psRate":"22.60","week52High":0.049,"institutionHeld":0,"latestPrice":0.035,"committee":-0.052447,"eps":-0.0175,"divideRate":0,"volume":523071,"delay":0,"ttmEps":-0.0175,"open":0.035,"prevYearClose":0.028,"prevWeekClose":0.034,"prevMonthClose":0.033,"prevQuarterClose":0.028,"fiveDayClose":0.034,"twentyDayClose":0.027,"sixtyDayClose":0.04,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAB.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-10-13","symbol":"PAB.AU","defaultRemindTime":1760310000000,"type":"split","dateTimestamp":1760274000000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"AU","date":"2021-11-03","symbol":"PAB.AU","defaultRemindTime":1635894000000,"type":"split","dateTimestamp":1635858000000,"forFactor":995841,"toFactor":1000000,"ratio":0.9958410000000001},{"market":"AU","date":"2020-11-11","symbol":"PAB.AU","type":"split","dateTimestamp":1605013200000,"forFactor":2147483647,"toFactor":2147483647,"ratio":0.99319}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":35109071,"yearFounded":2006,"employeeNum":10,"address":"168 Stirling Highway,Nedlands,Western Australia,Australia","zipCode":"6009","officePhone":"61 8 6165 8858"},"stockCompanyDetail":{"websiteUrl":"http://www.patrys.com","stockEarnings":[{"period":"1week","weight":0.0294},{"period":"1month","weight":0.25},{"period":"3month","weight":-0.1026},{"period":"6month","weight":1.3333},{"period":"1year","weight":0.1667},{"period":"ytd","weight":0.25}],"compareEarnings":[{"period":"1week","weight":0.002},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0231},{"period":"6month","weight":0.0492},{"period":"1year","weight":0.1818},{"period":"ytd","weight":0.0041}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.315789,"avgChangeRate":-0.023421},{"month":2,"riseRate":0.5,"avgChangeRate":-0.022957},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.042963},{"month":4,"riseRate":0.388889,"avgChangeRate":-0.044949},{"month":5,"riseRate":0.222222,"avgChangeRate":0.01782},{"month":6,"riseRate":0.277778,"avgChangeRate":0.091791},{"month":7,"riseRate":0.157895,"avgChangeRate":-0.099901},{"month":8,"riseRate":0.473684,"avgChangeRate":0.290084},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.007469},{"month":10,"riseRate":0.421053,"avgChangeRate":0.040395},{"month":11,"riseRate":0.210526,"avgChangeRate":-0.026724},{"month":12,"riseRate":0.421053,"avgChangeRate":-0.019673}],"exchange":"ASX","name":"Patrys Ltd","nameEN":"Patrys Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":null}}